TLDR Biotech

TLDR Biotech
Archive
Page 9

The Latest Biotech & Pharma Updates

Jun 22, 2024

📈📉 Biotech & Pharma Stock Market Recap | June 17 - 21, 2024

🧬 Winners, Losers, and Upcoming Earnings Calls

Anis Fahandej-Sadi

Jun 21, 2024

Biotech & Pharma Updates | June 18 - 20, 2024

Sapreta Therapeutics lands key DMD label expansion, Gilead's twice-yearly HIV prevention med scores 100% efficacy, iOnctura raises $86M, Takeda drops $230M on a facility expansion, and Bora makes US-based sterile manufacturing moves

Anis Fahandej-Sadi

Jun 19, 2024

Biotech & Pharma Updates | June 17 - 18, 2024

GSK has a double Ph3 win, Marea Therapeutics launches with $190M to go after remnant cholesterol, Hikma buys multiple assets and sites from Xeliia Pharmaceuticals, and Sanofi and Roche both sign big drug development partnership

Anis Fahandej-Sadi

Jun 18, 2024

Biotech & Pharma Updates | June 16 - 17, 2024

AstraZeneca & Merck both land FDA approvals for endometrial cancer, Takeda's epilepsy bet is up in flames, Merck lands a historic vaccine approval, and a BioNTech and MediLink Therapeutics ADC gets an FDA partial hold

Anis Fahandej-Sadi

Jun 17, 2024

Biotech & Pharma Updates | June 13 - 16, 2024

Vertex releases positive long term gene therapy data, Vaxart lands a big BARDA contract, AI drug discovery debuts on Hong Kong stock exchange, Kyverna has a rough week due to autoimmune data and 100% of something for two cancer biotechs

Anis Fahandej-Sadi

Jun 15, 2024

📈📉 Biotech & Pharma Stock Market Recap | June 10 - 14, 2024

🧬 Winners, Losers, and Upcoming Earnings Calls

Anis Fahandej-Sadi

Jun 14, 2024

Biotech & Pharma Updates | June 12 - 13, 2024

Pfizer's DMD hopes shattered in Ph3 (while also planning for 8 blockbusters by 2030), while JP Morgan closes $500M biotech fund, a new antibody player launches with $168M, and Eli Lilly gets an upgrade (from accelerated to full approval)

Anis Fahandej-Sadi

Jun 13, 2024

Biotech & Pharma Updates | June 11 - 12, 2024

BMS still has an M&A appetite, Ultragenyx has some bone-building Ph2/3 results, Eli Lilly's Alzheimer's approval could be good news for rivals Biogen and Eisai too, Foresite Capital raises a $900M life science fund, and Pfizer signs a discovery pact with ProFound Therapeutics in search of the next great obesity med

Anis Fahandej-Sadi

Jun 12, 2024

Biotech & Pharma Updates | June 10 - 11, 2024

Syntis Bio to take on GLP-1 giants, Ipsen's new FDA approval, an ADC and an "ADC-like" company both raise millions, cancer patient groups like AstraZeneca, and Pfizer takes an M&A break

Anis Fahandej-Sadi

Jun 11, 2024

Biotech & Pharma Updates | June 9 - 10, 2024

Eli Lilly gets full support from FDA advisory panel, GSK's RSV vaccine gets a label expansion, Moderna’s flu/covid combo passes Ph3, Amber Therapeutics raises $100M, Alumis plans an IPO, and the FDA gets curious about AI

Anis Fahandej-Sadi

Jun 10, 2024

Biotech & Pharma Updates | June 6 - 9, 2024

Geron lands first FDA approval after 34 years, Abbvie & Calico join FDA rare disease pilot, Rapport Therapeutics upsized IPO to $154M, and Eli Lilly could secure Alzheimer's throne

Anis Fahandej-Sadi

Jun 08, 2024

📈📉 Biotech & Pharma Stock Market Recap | June 3 - 7, 2024

🧬 Winners, Losers, and Upcoming Earnings Calls

Anis Fahandej-Sadi

First Back

5 6 7 8 9 10 11 12

Next Last